These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 28430350)

  • 21. Second-look surgery plus hyperthermic intraperitoneal chemotherapy for patients with colorectal cancer at high risk of peritoneal carcinomatosis: Does it really save lives?
    Cortes-Guiral D; Elias D; Cascales-Campos PA; Badía Yébenes A; Guijo Castellano I; León Carbonero AI; Martín Valadés JI; Garcia-Foncillas J; Garcia-Olmo D
    World J Gastroenterol; 2017 Jan; 23(3):377-381. PubMed ID: 28210074
    [TBL] [Abstract][Full Text] [Related]  

  • 22. HIPEC in ovarian cancer: treatment of a new era or is it the end of the pipeline?
    Cascales-Campos P; Gil J; Feliciangeli E; Parrilla P
    Gynecol Oncol; 2015 Nov; 139(2):363-8. PubMed ID: 26091936
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Peritoneal carcinomatosis from unusual cancer origins: Is there a role for hyperthermic intraperitoneal chemotherapy?
    Honoré C; Goéré D; Macovei R; Colace L; Benhaim L; Elias D
    J Visc Surg; 2016 Apr; 153(2):101-7. PubMed ID: 26698380
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Treatment of peritoneal carcinomatosis from ovarian cancer by surgical cytoreduction and hyperthermic intraperitoneal chemotherapy (HIPEC).
    Robella M; Vaira M; Marsanic P; Mellano A; Borsano A; Cinquegrana A; Sottile A; De Simone M
    Minerva Chir; 2014 Feb; 69(1):27-35. PubMed ID: 24675244
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Predictors of progression in high-grade appendiceal or colorectal peritoneal carcinomatosis after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.
    Baumgartner JM; Tobin L; Heavey SF; Kelly KJ; Roeland EJ; Lowy AM
    Ann Surg Oncol; 2015 May; 22(5):1716-21. PubMed ID: 25145504
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A comprehensive treatment for peritoneal metastases from gastric cancer with curative intent.
    Yonemura Y; Canbay E; Li Y; Coccolini F; Glehen O; Sugarbaker PH; Morris D; Moran B; Gonzaletz-Moreno S; Deraco M; Piso P; Elias D; Batlett D; Ishibashi H; Mizumoto A; Verwaal V; Mahtem H
    Eur J Surg Oncol; 2016 Aug; 42(8):1123-31. PubMed ID: 27160355
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Re: "cytoreductive surgery and hyperthermic intraperitoneal chemotherapy as upfront therapy for advanced epithelial ovarian cancer: multi-institutional phase II trial." - Proposal of a clinical trial of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in advanced ovarian cancer, the CHORINE study.
    Ansaloni L; De Iaco P; Frigerio L
    Gynecol Oncol; 2012 Apr; 125(1):279-81. PubMed ID: 22233688
    [No Abstract]   [Full Text] [Related]  

  • 28. Enterocutaneous fistula in patients with peritoneal malignancy following cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: Incidence, management and outcomes.
    Valle SJ; Alzahrani N; Alzahrani S; Traiki TB; Liauw W; Morris DL
    Surg Oncol; 2016 Sep; 25(3):315-20. PubMed ID: 27566038
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Peritoneal carcinomatosis 2011; it's about time for chemosurgery.
    Spiliotis JD; Halkia EA; Efstathiou E
    J BUON; 2011; 16(3):400-8. PubMed ID: 22006740
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Iterative procedures combining cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for isolated peritoneal recurrence.
    Vaira M; Robella M; Mellano A; Sottile A; De Simone M
    Int J Hyperthermia; 2014 Dec; 30(8):565-9. PubMed ID: 25430988
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Postoperative complications after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy affect long-term outcome of patients with peritoneal metastases from colorectal cancer: a two-center study of 101 patients.
    Baratti D; Kusamura S; Iusco D; Bonomi S; Grassi A; Virzì S; Leo E; Deraco M
    Dis Colon Rectum; 2014 Jul; 57(7):858-68. PubMed ID: 24901687
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Predictive and prognostic survival factors in peritoneal carcinomatosis from appendiceal cancer after cytoreductive surgery with hyperthermic intraperitoneal chemotherapy.
    Jimenez W; Sardi A; Nieroda C; Sittig M; Milovanov V; Nunez M; Aydin N; Gushchin V
    Ann Surg Oncol; 2014 Dec; 21(13):4218-25. PubMed ID: 24986239
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cytoreductive surgery and HIPEC for peritoneal carcinomatosis. A review on morbidity and mortality.
    Halkia E; Kopanakis N; Nikolaou G; Spiliotis J
    J BUON; 2015 May; 20 Suppl 1():S80-7. PubMed ID: 26051337
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Peritonectomy procedures and HIPEC in the treatment of peritoneal carcinomatosis from ovarian cancer: Long-term outcomes and perspectives from a high-volume center.
    Muñoz-Casares FC; Medina-Fernández FJ; Arjona-Sánchez Á; Casado-Adam Á; Sánchez-Hidalgo JM; Rubio MJ; Ortega-Salas R; Muñoz-Villanueva MC; Rufián-Peña S; Briceño FJ
    Eur J Surg Oncol; 2016 Feb; 42(2):224-33. PubMed ID: 26673283
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hyperthermic intraperitoneal chemotherapy (HIPEC) in ovarian cancer.
    Bakrin N; Classe JM; Pomel C; Gouy S; Chene G; Glehen O
    J Visc Surg; 2014 Oct; 151(5):347-53. PubMed ID: 25168575
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prognostic factors and oncologic outcome in 146 patients with colorectal peritoneal carcinomatosis treated with cytoreductive surgery combined with hyperthermic intraperitoneal chemotherapy: Italian multicenter study S.I.T.I.L.O.
    Cavaliere F; De Simone M; Virzì S; Deraco M; Rossi CR; Garofalo A; Di Filippo F; Giannarelli D; Vaira M; Valle M; Pilati P; Perri P; La Pinta M; Monsellato I; Guadagni F
    Eur J Surg Oncol; 2011 Feb; 37(2):148-54. PubMed ID: 21093205
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effectiveness and failures of a fast track protocol after cytoreduction and hyperthermic intraoperative intraperitoneal chemotherapy in patients with peritoneal surface malignancies.
    Cascales-Campos PA; Sánchez-Fuentes PA; Gil J; Gil E; López-López V; Rodriguez Gomez-Hidalgo N; Fuentes D; Parrilla P
    Surg Oncol; 2016 Dec; 25(4):349-354. PubMed ID: 27916165
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Importance of hyperthermic intraperitoneal chemotherapy (HIPEC) in ovarian cancer].
    Ferron G; Martinez A; Mery E; Querleu D; Thomas F; Chatelut E; Gladieff L
    Bull Cancer; 2009 Dec; 96(12):1243-52. PubMed ID: 19948452
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy for colorectal cancer: choosing the right candidates.
    LaRocca CJ; Tuttle TM
    Expert Rev Anticancer Ther; 2015; 15(8):859-61. PubMed ID: 26204905
    [No Abstract]   [Full Text] [Related]  

  • 40. Laparoscopic Hyperthermic Intraperitoneal Chemotherapy for Peritoneal Carcinomatosisfrom Gastric Cancer: Its Beneficial Effects on Reduction and Exact Evaluation of the Peritoneal Cancer Index.
    Takeshita K; Liu Y; Ishibashi H; Yonemura Y
    Am Surg; 2017 Nov; 83(11):1315-1320. PubMed ID: 29183538
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.